0001144204-17-004094.txt : 20170126 0001144204-17-004094.hdr.sgml : 20170126 20170126175644 ACCESSION NUMBER: 0001144204-17-004094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170125 FILED AS OF DATE: 20170126 DATE AS OF CHANGE: 20170126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Toutain Stephan CENTRAL INDEX KEY: 0001681658 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 17551160 MAIL ADDRESS: STREET 1: 135 BEAVER STREET STREET 2: C/O INTERLEUKIN GENETICS, INC. CITY: WALTHAM STATE: MA ZIP: 02453 4 1 v457637_form4.xml FORM 4 X0306 4 2017-01-25 0 0001037649 INTERLEUKIN GENETICS INC ILIU 0001681658 Toutain Stephan C/O INTERLEUKIN GENETICS, INC. 135 BEAVER STREET WALTHAM MA 02452 0 1 0 0 Chief Commercial Officer Stock Option (Right to Buy) 0.1237 2017-01-25 4 A 0 365093 0 A 2027-01-25 Common Stock 365093 365093 D The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on January 25, 2017, which was the grant date of the option. The option vests as to 25% of the shares on January 25, 2018, and 1/36th of the shares on the first day of each month beginning on February 1, 2018. /s/ Brian P. Keane, Attorney-in-Fact 2017-01-26